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Introduction
Threatened preterm labor (TPL) is the progression of cervical 
dilatation and ripening caused by regular uterine contractions 
occurring before 37 weeks of pregnancy, which may result 
in preterm birth. Preterm birth, the most common cause of 
neonatal mortality and morbidity worldwide [1,2], causes over 
70% of fetal death rates and approximately 50% of neonatal 
neural deficits [3-5]. Preterm birth occurs in 5 to 18% of preg-
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Objective
This study aimed to examine clinical practice patterns in the management of pregnant women admitted with 
threatened preterm labor (TPL) in Korea.
Methods
Data from women admitted with a diagnosis of TPL were collected from 22 hospitals. TPL was defined as regular uterine 
contractions with or without other symptoms such as pelvic pressure, backache, increased vaginal discharge, menstrual-like 
cramps, bleeding/show and cervical changes. Data on general patient information, clinical characteristics at admission, use of 
tocolytics, antibiotics, and corticosteroids, and pregnancy outcomes were collected using an online data collections system.
Results
A total of 947 women with TPL were enrolled. First-line tocolysis was administered to 822 (86.8%) patients. As a first-
line tocolysis, beta-agonists were used most frequently (510/822, 62.0%), followed by magnesium sulfate (183/822, 
22.3%), calcium channel blockers (91/822, 11.1%), and atosiban (38/822, 4.6%). Of the 822 women with first-line 
tocolysis, second-line tocolysis were required in 364 (44.3%). Of 364 with second-line, 199 had third-line tocolysis 
(37.4%). Antibiotics were administered to 29.9% of patients (284/947) with single (215, 22.7%), dual (26, 2.7%), 
and triple combinations (43, 4.5%). Corticosteroids were administered to 420 (44.4%) patients. Betamethasone was 
administered to 298 patients (71.0%), and dexamethasone was administered to 122 patients (29.0%).
Conclusion
Practice patterns in the management of TPL in Korea were quite various. It is needed to develop standardized practice 
guidelines for TPL management.
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nancies, and is also a common cause of hospitalization during 
the antenatal period [6-8]. With the aim of prolonging gesta-
tion, improving neonatal outcomes, and reducing the burden 
of maternal and fetal complications, various approaches to 
the management of preterm labor have been extensively in-
vestigated [9]. However, solid evidence regarding the effective-
ness of these approaches is still lacking, as some drugs have 
reportedly shown adverse effects. With the exception of some 
defined recommendations, i.e., single course of corticosteroids 
and tocolytic treatment up to 48 hours, clinical practice pat-
terns for TPL vary considerably between countries [10]. 
Although TPL treatment in Korea includes the use of tocolyt-
ics, antibiotics, and steroids, studies or surveys aimed at estab-
lishing treatment guidelines for the clinical management of 
TPL have been quite lacking until now. As the management of 
TPL differs from individual to individual, and from hospital to 
hospital, this study aimed to examine clinical practice patterns 
in the management of women with TPL in Korea.
Materials and methods
1.  Data collection
Pregnant women admitted to 22 hospitals with a diagnosis 
of TPL from January 1 to December 31, 2012 were enrolled 
in this study. Inclusion criteria at admission included women 
from 24+0 to 33+6 weeks’ gestation with singleton or twin 
pregnancies and diagnosis of TPL. TPL was defined as regular 
uterine contractions with or without other symptoms such as 
pelvic pressure, backache, increased vaginal discharge, men-
strual-like cramps, bleeding/show and cervical changes [11-
13]. Women with preterm premature rupture of membranes 
(PPROM), cervical insufficiency, triplet and higher-order multi-
fetal pregnancy, diabetes, renal disease, pregnancy associated 
hypertension, chronic hypertension, cardiovascular illness, 
symptomatic infectious diseases, chronic medical disorders, 
and those with a fetal structural or genetic anomaly were ex-
cluded from the study. The study protocol was developed and 
supervised by the Preterm Birth Research Group affiliated to 
the Korean Society of Maternal Fetal Medicine. Data were ob-
tained using an online data collection system available at the 
following website: http://fetalmed.or.kr/bbs/?code=preterm. 
Participants responded to multiple-choice or yes/no questions 
by clicking the appropriate button, and added numeric data 
values directly into blank boxes. Data on general patient in-
formation, clinical characteristics of the subjects at admission, 
tocolytics, antibiotics, and steroids use during hospitalization 
were collected retrospectively. The institutional review board 
approved this study (KUH1040027).
2.  General information and clinical characteristics of the 
subjects at admission
Basic information was collected according to the diagnosis giv-
en at admission. Clinical and obstetric characteristics of the pa-
tients were obtained which include maternal age, body mass 
index, blood pressure, parity, history of spontaneous preterm 
delivery, twin pregnancy, history of cerclage, myoma, uterine 
anomaly, pregnancy achieved through artificial reproductive 
technology, vaginal bleeding at admission.
3.  Tocolytics, antibiotics, and steroids administration
Tocolytic therapy including beta-agonists, magnesium sulfate, 
atosiban, and calcium channel blockers was administered 
using a first-line to third-line drug approach. Women who 
received other rarely administered or a combination of two or 
more tocolytics were excluded from the study. First-line tocoly-
sis was defined as tocolytic drug treatment firstly administered 
at admission, regardless of route of administration. Second- 
and third-line tocolysis were defined as treatment with an 
alternative tocolytic drug after the previous tocolysis treatment 
failed. Causes of tocolytic treatment failure leading to the 
unintended discontinuation of tocolytic treatment included 
side effects, poor tolerance, and insufficient efficacy. Although 
all women with TPL should not be treated with antibiotics, 
antibiotics in women with TPL can be used in cases of group 
B streptococcal infection, cervical infection, chorioamnionitis, 
etc. The antibiotic treatment patterns were investigated us-
ing the following variables: antibiotic treatment, frequency 
and duration of treatment, type of antibiotics, and type of 
regimen i.e., single, double or triple combination therapy. We 
also investigated the use of the antenatal corticosteroids. Two 
different regimens were used, which include four doses of 5 
mg dexamethasone intramuscular injections every 12 hours 
and two doses of 12 mg betamethasone intramuscular injec-
tions every 24 hours [14]. Patients who received two or more 
courses of corticosteroid therapy were excluded.
4.  Pregnancy outcomes
In women who delivered at term and in the participating hos-
pitals, pregnancy outcomes were collected which included ges-
tational age at delivery, mode of delivery, presence or absence 
of histologic chorioamnionitis. 
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Birth weight, one minute and five minutes Apgar score, and 
admission to neonatal intensive care unit (NICU) were investi-
gated as neonatal outcomes.
Results
1.  General information and clinical characteristics of the 
subjects at admission
A total of 947 pregnant women with a diagnosis of TPL were 
enrolled in this study. The frequency of admissions was increased 
in proportion to the number of gestational weeks (Fig. 1). Clini-
cal and obstetric characteristics in women with TPL are shown in 
Table 1. Nulliparous women comprised 63.6% of the total, and 
83 (8.8%) had a history of spontaneous preterm delivery.
2. Tocolytics, antibiotics, and steroids
The practice pattern of tocolytic therapy is summarized in Table 
2. Among 947 women hospitalized for TPL, first-line tocolysis 
was administered to 822 (86.8%) women. Beta-agonists were 
the most frequently used agents (510/822, 62.0%), followed 
by magnesium sulfate (183/822, 22.3%), calcium channel 
blockers (91/822, 11.1%), and atosiban (38/822, 4.6%). Of the 
822 women receiving first-line tocolytic treatment, 364 (44.3%) 
required a second-line drug. Similarly, women who received a 
second-line drug were switched to third-line tocolytic treatment 
(136/364, 37.4%). Side effects were most frequently found in 
beta-agonists (84/642, 13.1%) including maternal tachycardia, 
chest discomfort, dyspnea, tremor, pleural effusion, pulmonary 
edema, dizziness, uncontrolled blood glucose, tingling sensation 
in extremities, and elevated liver enzymes. Among the tocolytic 
agents, calcium channel blockers showed the most insufficient 
efficacy (43/104, 41.3%). Antibiotics were administered to 284 
women (284/947, 29.9%), with single (215, 22.7%), dual (26, 
2.7%), and triple antibiotic combination therapy (43, 4.5%) 
(Table 3). The single antibiotic most frequently administered 
was 2nd generation cephalosporin only with a median treat-
ment duration of 6 days. Among the triple antibiotic therapies, 
the combination of a 3rd generation cephalosporin + clarithro-
mycin + metronidazole was the most frequently used. Among 
women who received antenatal corticosteroid therapy (420/947, 
44.4%) for fetal lung maturation, 298 (71.0%) and 122 (29.0%) 
received betamethasone and dexamethasone, respectively (Fig. 
2). The completion rate of a course of corticosteroid therapy 
was higher in women receiving betamethasone than in those 
receiving dexamethasone.
3. Pregnancy outcomes
Of 947 pregnant women with TPL initially enrolled in this study, 
425 (44.9%), including 344 and 81 women with singleton and 
twin pregnancies, respectively, were followed up until delivery. 
Table 4 shows pregnancy outcomes of the 425 pregnant wom-
en with complete follow up.
Fig. 1. Frequency of hospital admission according to gestational age in 
women with threatened preterm labor. A trend shows that the number 
of hospital admission increased in proportion to gestational age.
Table 1. Clinical and obstetric characteristics of the subjects in-
cluded in the study (n=947)
Characteristics Value
Maternal age (yr) 32 (29–34)
Maternal body mass index (kg/m2) 23.4 (21.6–25.8)
Systolic blood pressure (mmHg) 110 (103–120)
Diastolic blood pressure (mmHg) 69 (60–74)
Nullipara 602 (63.6)
History of spontaneous preterm deliverya) 83 (8.8)
Twin pregnancy 144 (15.2)
Cerclage 46 (4.9)
Myoma 56 (5.9)
Uterine anomaly 8 (0.84)
Pregnancy by artificial reproductive technology 127 (13.4)
Vaginal bleeding at admission 118 (12.5)
hsCRP (Nb)=847) (mg/dL) 0.40 (0.14–0.85)
Values are presented as median (interquartile range) or n (%).
hsCRP, highly sensitive C-reactive protein.
a)Spontaneous preterm delivery includes deliveries by preterm labor, 
preterm premature rupture of membranes, and cervical insufficiency; 
b)Total number of patients who had a hsCRP test.
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Discussion
The term TPL is more often used in the clinical and investiga-
tional fields. However, as the definition of TPL is not yet well 
established, there is considerable variability between studies. 
The mechanism of preterm labor is not clear, thereby hindering 
the development of successful preventive methods and mak-
ing large practice variation for treatment of TPL. TPL has been 
defined as the presence of at least 3 regular and painful uter-
ine contractions within a 30-minute period [15], or the pres-
ence of at least two uterine contractions every 10 min for 60 
minutes, in combination with cervical changes ascertained on 
digital examination, and/or cervical length <30 mm measured 
by transvaginal ultrasonography [16]. Others have defined TPL 
as the occurrence of persistent premature uterine contractions 
between 20 and 37 weeks of gestation accompanied by other 
symptoms such as pelvic pressure, backache, increased vaginal 
discharge, menstrual-like cramps, bleeding/show and short-
ened cervix [17]. True preterm labor is known to involve regular 
painful uterine contractions accompanied by cervical changes. 
However, other clinical manifestations such as vaginal bleeding, 
mild or irregular contraction, menstrual-like cramping, PPROM, 
and short cervix that may overlap with true preterm labor, can 
hamper the clinical discrimination between true preterm labor 
and TPL. It is not easy to discriminate true preterm labor from 
TPL in clinical field. As most women presenting with TPL are 
at an increased the risk of preterm birth, they are usually ad-
mitted. Thus, pregnant women with TPL were enrolled in this 
study, though they might not have true preterm labor. 
Present treatments in TPL focus on the inhibition of preterm 
uterine contractions, at the end point of the cascade of the 
pathophysiological process. The treatment of women at risk of 
preterm delivery consists of administration of tocolytic drugs 
for 48 hours to allow for administration of corticosteroids and 
transportation of the patient to a center with NICU facilities in 
case if gestational age is <32 weeks [18]. Beta-agonists were 
the most frequently used tocolytics. Side effects occurred most 
frequently in women treated with beta-agonists (13.1%). This 
study provided an overview of the current insight in tocolysis in 
TPL in Korea.
Recent study showed that there was no demonstrable benefit 
in important neonatal outcomes with prophylactically or rou-
Table2. Practice pattern and unintended discontinuation of tocolytic therapy in 947 subjects with threatened preterm labor
Patient number of 
tocolysis
Discontinuation of 
tocolytic therapya) Side effects Poor tolerance Insufficient efficacy
First line tocolysis
Beta-agonist 510 176 (34.5) 67 (13.1) 22 (4.3) 87 (17.1)
Magnesium sulfate 183 54 (29.5) 3 (1.6) 7 (3.8) 44 (24.0)
Atosiban 38 4 (10.5) 0 (0.0) 0 (0.0) 4 (10.5)
Calcium channel blocker 91 44 (48.4) 1 (1.1) 0 (0.0) 43 (47.3)
Second line tocolysis
Beta-agonist 109 56 (51.4) 16 (14.7) 1 (0.9) 39 (35.8)
Magnesium sulfate 85 25 (29.4) 2 (2.4) 3 (3.5) 20 (23.5)
Atosiban 163 26 (16.0) 0 (0.0) 0 (0.0) 26 (16.0)
Calcium channel blocker 7 0 (0.0) 0 (0.0) 0 (0.0) 0 (0.0)
Third line tocolysis
Beta-agonist 23 6 (26.1) 1 (4.3) 0 (0.0) 5 (21.7)
Magnesium sulfate 6 1 (16.7) 0 (0.0) 0 (0.0) 1 (16.7)
Atosiban 101 16 (15.8) 0 (0.0) 0 (0.0) 16 (15.8)
Calcium channel blocker 6 0 (0.0) 0 (0.0) 0 (0.0) 0 (0.0)
Overall tocolysis
Beta-agonist 642 238 (37.1) 84 (13.1) 23 (3.6) 131 (20.4)
Magnesium sulfate 274 80 (29.2) 5 (1.8) 10 (3.6) 65 (23.7)
Atosiban 302 46 (15.2) 0 (0.0) 0 (0.0) 46 (15.2)
Calcium channel blocker 104 44 (42.3) 1 (1.0) 0 (0.0) 43 (41.3)
Values are presented as n or n (%).
a)The causes of unintended discontinuation of tocolytic therapy included drug side effects, poor tolerance, and insufficient efficacy.
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tinely giving antibiotics to women in preterm labor with intact 
membranes in the absence of overt signs of infection [19]. It is 
unknown that in utero exposure of various antibiotics is safe 
on the preterm neonate. Nevertheless, the patterns of antibi-
otics use for TPL were quiet variable, and treatment duration 
was about 5 to 6 days in Korea. Based on this study, the rate 
of antibiotics use was very high in preterm labor with intact 
membranes. It is needed that the antibiotics use is restricted to 
specific cases such as chorioamnionitis, cervical infection.
Although dexamethasone may have some benefits compared 
with betamethasone such as less intraventricular hemorrhage, 
and a shorter length of stay in the NICU, it remains unclear 
whether one corticosteroid has advantages over another, and 
there are no available long-term results [14]. In this study, be-
tamethasone is more frequently used and higher completion 
rate than dexamethasone in Korea. This discrepancy may be ex-
plained by a higher tolerability of the betamethasone regimen, 
as a total of two doses were administered intramuscularly every 
24 hours, compared with four dexamethasone doses adminis-
tered intramuscularly every 12 hours.
This retrospective study had several limitations. First, because 
medical records differed between institutions, the collection of 
uniformed patient data was difficult. Second, the criteria for 
admission and treatment in pregnant women with TPL also dif-
fered between hospitals. For example, pregnant women who 
had regular uterine contractions alone without cervical changes 
Table 3. Pattern of antibiotic usage in the management of threatened preterm labor
Frequency Days of treatment
Single antibiotics (n=215)
Cephalosporin
1st generation 20 (9.3) 6 (1–11)
2nd generation 110 (51.2) 6 (1–39)
3rd generation 6 (2.8) 5 (1–21)
Penicillin
Amoxicillin 1 (0.5) 5 (5–5)
Ampicillin-Sulbactama) 55 (25.6) 5 (1–28)
Piperacillin 5 (2.3) 5 (1–14)
Others
Azithromycin 8 (3.7) 5 (1–15)
Clarithromycin 6 (2.8) 5 (3–7)
Metronidazole 2 (0.9) 6 (3–8)
Erythromycin 1 (0.5) 4 (4–4)
Clindamycin 1 (0.5) 5 (5–5)
Two antibiotics combination (n=26)
1st generation cephalosporin + clarithromycin 9 (34.6) 7 (2–12)
2nd generation cephalosporin + clarithromycin 9 (34.6) 10 (1–30)
2nd generation cephalosporin + metronidazole 2 (7.7) 8 (7–9)
3rd generation cephalosporin + metronidazole 2 (7.7) 4 (2–5)
Ampicillin-sulbactama)+ azithromycin 2 (7.7) 5 (2–7)
Others 2 (7.7) -
Three antibiotics combination (n=43)
3rd generation cephalosporin + clarithromycin + metronidazole 21 (48.8) 5 (1–29)
2nd generation cephalosporin + clarithromycin + metronidazole 15 (34.9) 5 (1–10)
Ampicillin-sulbactama)+ clarithromycin + metronidazole 2 (4.7) 5 (2–7)
1st generation cephalosporin + clarithromycin + metronidazole 2 (4.7) 5 (3–7)
2nd generation cephalosporin + azithromycin + metronidazole 2 (4.7) 3 (2–4)
Others 1 (2.3) -
Values are presented as n (%) median (range).
a)Ampicillin-sulbactam was regarded as a single antibiotic. 
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were hospitalized in some institutions, but in others, women 
with both, regular uterine contractions and cervical changes 
were admitted. Some hospitals administered single antibiotics 
routinely, whereas others administered dual and triple antibiotic 
combinations. Third, because of a lack of NICU beds, maternal 
medical problems, or fetal congenital anomalies, a consider-
able number of women with TPL experienced one or more 
hospital-to-hospital transfers, which may have resulted in losses 
to follow up, and difficulties in the collection of serial medical 
data. Fourth, the diagnostic criteria of neonatal morbidity such 
as respiratory distress syndrome, bronchopulmonary dysplasia, 
necrotizing enterocolitis, and retinopathy of prematurity were 
also different between institutions. Fifth, in this study, the data 
for the maintenance therapy after initial tocolysis and the use 
of magnesium sulfate for neuroprotection effect were not col-
lected. Further study for these treatments will be studied in the 
near future.
The results of this retrospective multicenter study have pro-
vided baseline data on practice patterns for TPL. However, 
further efforts are needed in order to develop a standardized 
registration system for women with TPL, in which pregnancy 
and neonatal outcome data are linked to nationwide neonatol-
ogy and preventive medicine multicenter registries. The data 
generated from these interconnected systems will provide pow-
erful information to ultimately improve pregnancy and neonatal 
outcomes, as well as facilitate the development of standardized 
practice guidelines for TPL management in Korea.
Table 4. Pregnancy outcomes of pregnant women followed up until delivery
Obstetric outcome First baby outcome Second baby outcome
Singleton pregnancy (n=344)
Gestational age at delivery (wk) 33.0 (31.3–37.0)
Delivery at ≥37+0 weeks’ gestation 108 (31.4)
Cesarean delivery 163 (47.4)
Histologic chorioamnionitis rate 65/236 (27.5)
Birth weight (kg) 2.30 (1.74–2.96)
1 min Apgar score < 5 46 (13.4)
5 min Apgar score < 7 46 (13.4)
Admission to NICU 208 (60.5)
Twin pregnancy (n=81)
Gestational age at delivery (wk) 31.2 (28.0–33.3)
Delivery at ≥37+0 weeks’ gestation 26 (32.1)
Cesarean delivery 65 (80.2)
Histologic chorioamnionitis 17/57 (29.8)
Birth weight (kg) 1.92 (1.51–2.13) 1.89 (1.42–2.10)
1 min Apgar score <5 10 (12.3) 15 (18.5)
5 min Apgar score <7 8 (9.9) 13 (16.0)
Admission to NICU 50 (61.7) 47 (58.0)
Values are presented as median (interquartile range), or n (%), or n/Na) (%).
NICU, neonatal intensive care unit.
a)Total number of placental histologic evaluation.
Fig. 2. Betamethasone was more frequently used than the dexametha-
sone (71.0% vs. 29.0%) (A). The completion rate of betamethasone 
treatment was higher than that of dexamethasone (B,C).
A
B  C
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